Cure8 news brief
Why This Matters
Reported IBD rates in Brazil increased markedly between 2012 and 2025, which could mean more people will need diagnosis, specialist care, and medications. Rising numbers also matter for public-health planning and research into causes.
Who Should Pay Attention
Adult patients with IBD, newly diagnosed people, clinicians and health-system planners in Brazil, and epidemiology researchers.
Study Snapshot
What To Know
The article summarizes a study presentation (not a peer-reviewed paper) that found IBD prevalence/incidence rose from about 30 to 158 cases per 100,000 over the 13-year period. The report names Crohn's disease and ulcerative disease as included diagnoses.
The story is based on conference data reported in Brazilian news outlets; the Ground News page aggregates those reports. The item does not provide detailed methods, raw data, or patient-level findings in the extracted text.
Important details such as whether the change reflects improved diagnosis, coding practices, registry expansion, true incidence rise, or demographic shifts are not included in the article text provided.
Keep In Mind
The source summarizes a study presented at a national congress; the article does not give study methods or show peer-reviewed publication. Increases could reflect greater detection or reporting as well as true rises in disease.
Source Details
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.